REspiratory diSEAse cohoRt Studies of CHinese Medicine for Pneumonia (RESEARCH-Pneumonia)

ConditionPneumonia
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorHenan University of Traditional Chinese Medicine

About this trial

The purpose of this study is to evaluate the clinical efficacy and safety of dialectical treatment in the patients with pneumonia after discharge in a prospective cohort study: one is the Traditional Chinese Medicine (TCM) cohort, which has been evaluated and has certain effects; The other is a non traditional Chinese medicine queue.

Eligibility criteria

Qualifiers

Hospitalized patients with a confirmed diagnosis of pneumonia (HAP, CAP).

Age ≥18 years.

Signed informed consent form.

Disqualifiers

Patients with confusion, consciousness disorders, dementia, and various mental illnesses;

Patients with altered mental status, dementia, consciousness disorders, or various psychiatric conditions;

Those who are completely unable to care for themselves or are bedridden long-term; and those currently participating in other clinical drug trials.

Known to be allergic to treatment drugs.

Trial design

Treatments tested in this trial

  • TCM

Treatment groups

5,000 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Henan University of Traditional Chinese Medicine

Lead sponsor

Wuhan No.1 Hospital

Collaborator

Hebei Provincial Hospital of Traditional Chinese Medicine

Collaborator

Shanghai University of Traditional Chinese Medicine

Collaborator

Qingdao Hiser Medical Group

Collaborator

The First Affiliated Hospital of Zhejiang Chinese Medical University

Collaborator

Shaanxi Hospital of Traditional Chinese Medicine

Collaborator